Restoring Metabolic-Inflammatory Homeostasis: Curcumin's Multi-Layered Defense Against Chondrocyte Dysfunction

Area of Science:

• Biochemistry
• Molecular Biology
• Systems Biology

Background:

• Osteoarthritis (OA) pathogenesis involves complex inflammatory and metabolic interactions that lead to cartilage degradation.
• The precise mechanisms by which therapeutic compounds like curcumin exert their effects in OA remain incompletely understood.

Purpose of the Study:

• To elucidate the molecular and metabolic mechanisms underlying curcumin's effects on interleukin-1 beta (IL-1β)-induced human chondrocytes.
• To identify potential therapeutic targets and biomarkers for osteoarthritis treatment.

Main Methods:

• Integrated untargeted metabolomics and transcriptomic analysis of four Gene Expression Omnibus (GEO) datasets.
• Applied machine learning algorithms (LASSO, Random Forest, XGBoost) to identify key molecular signatures.
• Validated findings using quantitative reverse transcription PCR (qRT-PCR) on IL-1β-stimulated human chondrocytes.

Main Results:

• Interleukin-1 beta (IL-1β) significantly depleted tricarboxylic acid (TCA) cycle intermediates, such as pyruvate and malate, in chondrocytes.
• High-dose curcumin (10 μM) treatment restored these depleted metabolites towards normal levels.
• A six-gene signature (NFKBIA, MMP9, LCK, TDO2, HADHA, VEGFA) was identified with excellent discriminative performance for OA.
• Curcumin downregulated pro-inflammatory genes (JUN, IL6, PTGS2, CCL20, MMP9) and upregulated the NF-κB inhibitor NFKBIA.

Conclusions:

• Curcumin modulates the intricate metabolic and inflammatory networks within osteoarthritis chondrocytes.
• Nuclear factor kappa-light-chain-enhancer of activated B cells inhibitor alpha (NFKBIA) emerges as a potential key mediator in curcumin's therapeutic action.
• This research offers a mechanistic framework for the development of novel drug-like molecules for osteoarthritis.